President Trump Begins Treatment With Remdesivir from Gilead Sciences

President Trump Begins Treatment With Remdesivir from Gilead Sciences

The President's physicians started him on a course of treatment with an antiviral drug authorized to treat hospitalized COVID-19 patients.